Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,293,873
-
Share change
-
+2,307,492
-
Total reported value
-
$9,126,000
-
Price per share
-
$1.45
-
Number of holders
-
14
-
Value change
-
+$3,340,082
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of RESHAPE LIFESCIENCES INC - COM (RSLS) as of Q1 2018
As of 31 Mar 2018,
RESHAPE LIFESCIENCES INC - COM (RSLS) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,293,873 shares.
The largest 10 holders included
New Leaf Venture Partners, L.L.C., SV Health Investors, LLC, INTERNATIONAL BIOTECHNOLOGY TRUST PLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, US BANCORP \DE\, BlackRock Inc., CITADEL ADVISORS LLC, NORTHERN TRUST CORP, and UBS Group AG.
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.